Hugh M. McClure

FDA investigator

Appears on 5 documents from 2013 to 2021, most often at sites in Texas. Most often cites written procedures; deviations (21 CFR 211.100).

5
Documents on file
4.0
Observations per 483
2013
First seen
2021
Most recent

What they cite most

From 16 observations

Activity by year

2013: 3, 2020: 1, 2021: 1

Where

Texas 2 · Germany 1 · Maryland 1 · Ohio 1

Is Hugh M. McClure coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Ricerca Biosciences, LLCAug 13, 2021 · Painesville, Ohio
483 Rommelag CDMO GmbHFeb 18, 2020 · Sulzbach-Laufen, Germany
Warning letter Warning letter, Dec 3, 2013Dec 3, 2013 · Houston, Texas
483 Stanislaw R Burzynski, M.DMar 15, 2013 · Houston, Maryland
483 Burzynski Research InstituteMar 15, 2013 · Houston, Texas

About this profile

What does Hugh M. McClure inspect?

Hugh M. McClure appears on 5 documents on file covering 4 sites, most often in Texas.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 312.62(a) and 21 CFR 211.166.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Hugh M. McClure is dated Aug 13, 2021.